IL33 and chronic gastritis: In the SAMP model of chronic gastritis, eosinophils appear to be the main cell type driving M2 macrophage activation, and depleting eosinophils has a similar effect as blocking IL-33 in regard to reducing gastric M2 macrophage activity, which in turn, can also release IL-33, resulting in a vicious cycle that fuels itself.